Commerce Advisors
BMY icon

Commerce Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Commerce Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$919K Buy
14,723
+35
+0.2% +$2.21K 0.43% 34
2026
Q2 		$846K Buy
14,688
+43
+0.3% +$2.47K 0.46% 36
2026
Q1 		$888K Buy
+14,645
New +$854K 0.75% 32

Other funds holding BMY

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Independent Franchise Partners
Independent Franchise Partners London, United Kingdom $16.1B AUM 4.39% 1-Year Est. Return

Commerce Advisors's BMY Position: Q3 2026 in Review

Commerce Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.24% in Q3 2026, buying an estimated $2.21K and bringing the position to 14,723 shares worth $919K. The position accounts for 0.43% of the portfolio, ranked #34.

Commerce Advisors first reported a position in BMY in Q1 2026 and has held it in 3 quarters since. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Commerce Advisors held 14,723 shares of Bristol-Myers Squibb worth $919K as of Q3 2026.
  • Commerce Advisors bought 35 Bristol-Myers Squibb shares in Q3 2026, an estimated $2.21K.
  • Bristol-Myers Squibb made up 0.43% of Commerce Advisors's portfolio in Q3 2026, its #34 holding.
  • Commerce Advisors first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 3 quarters since.
  • 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Commerce Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.